Tag:
Kyowa Hakko Kirin
Latest Headlines
Latest Headlines
Aveo on a hiring spree as it preps for the launch of tivozanib
The fast-growing developer tells The Boston Globe that it plans to hire 120 new staffers this year in preparation for the likely upcoming launch of tivozanib.
Fujifilm presses biosimilars ambition
Consumer electronics giant Fujifilm is advancing its effort to become a biosimilars player. It agreed earlier this month to a 50-50 joint venture with biotech Kyowa Hakko Kirin, reports Reuters. The
M&A fills patent holes, fuels geographic expansion
Three deals now in the works embody three very different trends. Yet another Japanese drugmaker is expanding westward by snapping up a smaller pharma company. A U.S. company is buying a
Kyowa acquiring ProStrakan for £300M
Japan's Kyowa Hakko Kirin has snagged Scotland's ProStrakan in a £300 million deal. "As one of our licensees, KHK is a known quantity and the rationale behind the deal is for KHK to use
